Description
Elseiver Contraception Your Questions Answered 7ed by Guillebaud, John
This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. _x000D__x000D__x000D__x000D_Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either:_x000D__x000D__x000D_Tricycling, the 84/4 regimen, or totally continuous use (365/365), _x000D_OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days_x000D__x000D_New methods, and their importance or otherwise:_x000D__x000D__x000D_Intrauterine system: Jaydess® _x000D_Subcutaneous, self-injectable alternative to Depo-Provera: Sayana® Press_x000D_24/4 combined hormonal contraceptives: Zoely®, Eloine®_x000D_Diaphragm: Caya®_x000D__x000D_Updates_x000D__x000D__x000D_Quick starting and bridging (the Proving not Pregnant Protocol)_x000D_Emergency contraception (EC), how advice differs for ulipristal acetate EC_x000D_Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)_x000D__x000D__x000D__x000D__x000D_Question and answer format_x000D_Important information boxes_x000D_Unwanted side effects boxes_x000D_Frequent patient questions at the end of relevant chapters_x000D_Management advice_x000D_Follow-up advice_x000D_Comes with free e-book on ExpertConsult for the first time_x000D__x000D_This seventh edition has been completely revised and updated, incorporating relevant WHO and national guidance documents: therefore imparting best evidence-based practice for all methods. _x000D__x000D__x000D__x000D_Combined oral contraceptives (COCs) Based on the long-established evidence that 7 days of routinely not-taking pills in each cycle is too long for maintained ovarian suppression - and this necessarily leads to too little margin for errors in pill-taking - the authors recommend that providers switch to a new norm for all users of either:_x000D__x000D__x000D_Tricycling, the 84/4 regimen, or totally continuous use (365/365), _x000D_OR, for women who remain keen to see monthly pill-bleeds (which are completely unnecessary for health), one of the regimens (24/4 or 21/4) that shorten the contraception-non-taking time to 4 days_x000D__x000D_New methods, and their importance or otherwise:_x000D__x000D__x000D_Intrauterine system: Jaydess® _x000D_Subcutaneous, self-injectable alternative to Depo-Provera: Sayana® Press_x000D_24/4 combined hormonal contraceptives: Zoely®, Eloine®_x000D_Diaphragm: Caya®_x000D__x000D_Updates_x000D__x000D__x000D_Quick starting and bridging (the Proving not Pregnant Protocol)_x000D_Emergency contraception (EC), how advice differs for ulipristal acetate EC_x000D_Drug metabolism (implications with norethisterone) and interactions (eg affecting lamotrigine)_x000D__x000D__x000D__x000D__x000D_Intermittent quizzes for CPD portfolio purposes_x000D_Now on ExpertConsult_x000D_